VanEck Semiconductor ETF vs DENTSPLY SIRONA Inc — how do they compare? VanEck Semiconductor ETF trades at $588, while DENTSPLY SIRONA Inc trades at $11.43 (market cap $2.31B). The key difference: DENTSPLY SIRONA Inc pays a 5.04% dividend while VanEck Semiconductor ETF pays none, and VanEck Semiconductor ETF is trading nearer its 52-week high, DENTSPLY SIRONA Inc nearer its low. Which is the better fit depends on your goals.
| SMH | XRAY | |
|---|---|---|
52-Week High | $668.91 | $14.68 |
52-Week Low | $286.43 | $9.64 |
Market Cap | — | $2.31B |
Sector | — | Health |
Enterprise Value | — | $4.39B |
Dividend Yield | — | 5.04% |
Signals from Pluang's Aura AI — not financial advice
SMH, the VanEck Semiconductor ETF, trades at $588.7, up 3.39% ($19.29) in the last session, with a bullish technical signal driven by moving averages. The ETF holds major semiconductor stocks but lacks disclosed financial ratios. Recent news highlights institutional buying, such as Ferguson Shapiro's $4.53 million investment (SEC filing, August 10, 2026), and mixed sentiment from analysts, including a downgrade to Hold by Seeking Alpha (August 10, 2026).
Outlook is cautiously optimistic, supported by AI-driven demand and global semiconductor initiatives, like South Korea's $3.52 billion fund (Reuters, August 10, 2026). Risks include tariff impacts from Trump's polysilicon policy and volatility from concentrated holdings. Investors should weigh growth potential against sector-specific headwinds.
DENTSPLY SIRONA (XRAY) trades at $11.40, down 2.23% amid ongoing revenue declines and negative profitability. The stock shows bearish technical signals with support at $11 and resistance at $12. Recent Q2 2026 earnings beat expectations with $0.52 EPS but revenue fell 4.1% year-over-year to $898 million, reflecting persistent challenges in dental markets. The company maintains a 'Hold' analyst consensus with a $11.50 price target while executing its turnaround strategy.
Investment outlook remains cautious given six consecutive quarters of revenue declines and negative net margins. The company's restructuring efforts and new CFO appointment offer potential for operational improvement, but weak European demand and competitive pressures pose significant headwinds. With debt-to-asset ratio rising to 42.88% in 2025, financial leverage adds risk to the recovery thesis.
Trailing returns across standard periods
Latest headlines on both assets
The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →